Stroke in the diabetic patient

Diabetes Care

Volumn 17, Issue 3, 1994, Pages 213-219

  Bell, David S H ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PREVALENCE; RACE; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0028055133     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.17.3.213     Document Type: Article

References (64)

1. Gilman S: Advances in neurology (Part II). N Engl J Med 326:1671-76, 1992
2. Aronson SM: Intercranial vascular lesions in patients with diabetes mellitus. J Neuropathol Exp Neurol 23:183-96, 1973
3. Adams HP, Patman SF, Kassell NF, Tomer JC: Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol 41:1033-35, 1984
4. Pullicino PM, Xuereb M, Aquiliana J, Piedmonte MR: Stroke following acute myocardial infarction in diabetics. J Intern Med 231:287-93, 1992
5. Weinberger J, Biscarra V, Weisberg MK, Jacobson JH: Factors contributing to stroke in patients with atherosclerotic disease of the great vessels: the role of diabetes. Stroke 16:709-12, 1983
6. Alex M, Baron EK, Goldenberg S, Bumenthal HT: An autopsy of cerebrovascular accidents in diabetes mellitus. Circulation 25:663-73, 1962
7. Kuebler TW, Bendick PJ, Fineberg SE, Markand ON, Norton JA Jr, Vinicor FN, Clark CM Jr: Diabetes mellitus and cerebrovascular disease: prevalence of carotid artery occlusive disease and associated risk factors in 482 adult diabetic patients. Diabetes Care 6:274-78, 1983
8. Bell ET: A postmortem study of vascular disease in diabetes. Arch Pathol 53:444-55, 1952
9. Mohr JP, Lacunes in Bamett HJM, Stein BM, Mohr JP, Yatsu FM (Eds.): Stroke Pathophysiology, Diagnosis, and Management. Vol 2. New York, Churchill Livingstone, 1986, p. 475-96
10. Dandona P, James IM, Newburg PA, Wollard ML, Beckett AG: Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. Br Med J 2:325-26, 1978
11. Burn WK, Machin D, Waters WE: Prevalence of migraine in patients with diabetes. Br Med J 289:1579-80, 1984
12. Wolf PA, Kannel WB, Verter J: Current status of stroke risk factors. In Neurologic Clinics. Barnett HJM, Ed. Philadelphia, Saunders, 1983, p. 317-43
13. Hadden WC, Harris MI: Prevalence of diagnosed diabetes, undiagnosed diabetes, and impaired glucose tolerance in adults 20-74 years of age. In Vital and Health Statistics-Series II: Data From the National Health Survey. National Center for Health Statistics, 1987, p. 1-55.
14. Roehmhodt ME, Palumbo PJ, Whisnant JP, Elusback LR: Transient ischemic attack and stroke in a community-based diabetic cohort. Mayo Clin Proc 58:56-58, 1983
15. Kuller L, Anderson H, Peterson D, Cassel J, Spiers P, Curry H, Paegel B, Saslaw M, Sisk C, Wilber J, Millward D, Winklestein W, Lilienfield A, Seltser R: Nationwide cerebrovascular disease morbidity study. Stroke 1:86-99, 1970
16. Barker WH, Feldt KS, Felbel JH: Community surveillance of stroke in persons under 70 years old. Am J Public Health 73:260-65, 1983
17. Herman B, Leyten ACM, Van Luijk JH, Frenken CWGM, Op DE, Coul AAW, Schulte BPM: An evaluation of risk factors for stroke in a Dutch community. Stroke 13:334-39, 1982
18. Loug S, Melamed E, Cahane E, Carmen A: Hypertension and diabetes as risk factors in stroke patients. Stroke 4:751-59, 1973
19. Ostfeld AM, Shekelle RB, Kiawans H, Tufo HM: Epidemiology of stroke in an elderly welfare population. Am J Public Health 64:450-58, 1974
20. Stallones R, Dyken M, Fang HCH: Epidemiology for stroke facilities planning. Stroke 3:360-71, 1972
21. Kagan A, Popper JS, Rhoads GG: Factors related to stroke incidence in Hawaii in Japanese men. Stroke 11:14-21, 1980
22. Lindegard B, Hillbom M: Associations between brain infarction, diabetes, and alcoholism: observations from the Gothenburg population cohort study. Acta Neurol Scand 75:195-200, 1987
23. Gray CS, French JM, Bates D, Cartlidge NE, Venables GS, James OF: Increasing age, diabetes mellitus, and recovery from stroke. Postgrad Med J 65:720-24, 1989
24. Riddle MC, Hart J: Hyperglycemia recognized and unrecognized as a risk factor for stroke and transient ischemic attacks. Stroke 13:356-59, 1982
25. Lamk S, Ma JT, Woo E, Lam C, Yu YL: High prevalence of undiagnosed diabetes among Chinese patients with ischemic stroke. Diabetes Res Clin Pract 14:133-37, 1991
26. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick FJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750-55, 1987
27. Deckert T, Poulsen JE, Larsen M: Prognosis of diabetics with diabetes onset before age thirty-one. Diabetologia 14:363-70, 1976
28. Tunbridge WMG: Factors contributing to deaths of diabetics under fifty years of age. Lancet 2:569-72, 1981
29. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Decken T: Coronary heart disease in young type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144-48, 1987
30. Jensen T, Stender S, Deckert T: Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31:142-45, 1988
31. Jones SL, Close CF, Matlock NM, Jarrett J, Keen H, Viberti GC: Plasma lipid and coagulation factor concentrations in insulin-dependent diabetic patients with microalbuminuria. Br Med J 298:487-90, 1989
32. Rischen-Vos J, van der Woode FJ, Tegzess AM, Zwinderman AH, Goozen HC, van den Akker PJ, van Es LA: Increased morbidity and mortality in patients with diabetes mellitus after kidney transplantation as compared with nondiabetic patients. Nephrol Dial Transplant 7:433-37, 1992
33. Gray CS, Taylor R, French JM, Albert KG, Venables GS, James OF, Shaw DA, Cartlidge NES, Bates D: The prognostic value of stress hyperglycemia and previously unrecognized diabetes in acute stroke. Diabetic Med 4:237-40, 1987
34. Cox NH, Lorains JW: The prognostic value of blood glucose and glycosylated estimation in persons with stroke. Postgrad Med J 62:7-10, 1986
35. Kittner SJ, White CR, Losonczy KG, Wolf PA, Hebel JR: Black-white differences in stroke incidence in a national sample: the contribution of hypertension and diabetes mellitus. JAMA 264:1267-70, 1990
36. Dustan HP: Growth factors and racial differences in severity of hypertension and renal disease. Lancet 339:1339-40, 1992
37. Abbot RD, Donahue RP, MacMahon SW, Reed DM, Yunko K: Diabetes and the risk of stroke: The Honolulu Heart Program. JAMA 257:949-52, 1987
38. Barret-Connor E, Khaw KT: Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol 128:116-23, 1988
39. Emara MK, Saadah AM, Tohfa YA, Guindi RT, Gupta RK, Senthilselvan A: The hematocrit value in diabetic patients with ischemic stroke. Diabetes Res 12: 189-92, 1989
40. Stern MP, Haffner SM: Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 6:123-30, 1980
41. Webster P: The natural history of stroke in diabetic patients. Acta Med Scand 207: 417-24, 1980
42. Palumbo PJ, Elveback LR, Whisnant JP: Neurological complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol 19:593-601, 1978
43. Pulsinelli WA, Levy PE, Sigsbee B, Scherer P, Plum F: Increased damage after ischemic attacks in patients with hyperglycemia with or without established diabetes mellitus. Am J Med 74:540-44, 1983
44. Melamed E: Reactive hyperglycemia in patients with acute stroke. J Neurol Sci 29:267-75, 1976
45. Berger C, Hakim IM: The association of hyperglycemia with cerebral edema in stroke. Stroke 17:865-71, 1986
46. McCall AL: Perspectives in diabetes: the impact of diabetes on the CNS. Diabetes 41:557-70, 1992
47. Smith ML, Von Hanwehr R, Siesjo BK: Changes in extra and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats. J Cereb Blood Flow Metab 6:574-83, 1986
48. Rehncrona S, Rosen I, Siesjo BK: Brain lactic acidosis and ischemic cell damage: biochemistry and neurophysiology. J Cereb Blood Flow Metab 1:297-311, 1981
49. Collins RC, Dobkin BH, Choi DW: Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann Intern Med 110:992-1000, 1989
50. Olney JW, Labrayere J, Wang G, Wozniak DF, Price MT, Sesma MA: NMDA antagonist neurotoxicity's mechanism and prevention. Science 254: 1515-18, 1991
51. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105-11, 1986
52. Siesjo BK, Bengtsson F: Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab 9:127-40, 1989
53. Berger L, Hakim AM: Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats. J Cereb Blood Flow Metab 9:58-64, 1986
54. The Steering Committee of the Physicians Health Study Research Group: Preliminary report findings from the aspirin component of the ongoing Physicians Health Study. N EnglJ Med 318:262-64, 1988
55. Antiplatelet Trialists Collaboration: Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 296:320-31, 1988
56. Sagel J, Colwell JA, Crook L, Lamina M: Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 83:733-38, 1975
57. Grotta JC, Noms JW, Kumm B, the TASS Baseline and Angiographic Data Subgroup: Prevention of stroke with ticlopidine: who benefits most? Neurology 42: 111-15, 1992
58. Peto R, Gray R, Collins R: Randomized trial of prophylactic daily aspirin in British male doctors. Br Med J 296:313-16, 1988
59. Colwell JA, Bingham SF, Abraira C, Anderson JW, Comstock JP, Kwaan HC, and The Cooperative Study Group: Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene, II: effects of aspirin and dipyridamole on atherosclerotic vascular disease rates. Diabetes Care 9:140-48, 1986
60. Sivenius T, Laako M, Riekkinen P Sr, Smets P, Lowanthal A: European Stroke Prevention Study: Effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke 23:851-54, 1992
61. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis. N Engl J Med 325:445-53, 1991
62. Campbell DR, Hoar CS, Wheelock FC, Jr: Carotid artery surgery in diabetic patients. Arch Surg 119:1405-407, 1984
63. Mori E, Yomeda Y, Ohksawa S: Double-blind placebo-controlled trial of recombinant tissue plasminogen activator (rt-PA) in acute carotid stroke. Neurology 41 (Suppl. 1):347, 1991
64. Steinberg GK, Saleh J, Kunis D, DeLaPaz R, Zarnegar SR: Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits. Stroke 20:1247-52, 1989